News Related News

DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris

HEERLEN, The Netherlands and EMERYVILLE, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that they have enhanced their [...]

By | November 17th, 2017|Biofuels, Chemicals, Energy & Environment, News|

Why Scientists Can’t Do Business

Everyone knows there’s only one place for scientists ­– and that’s in the lab. Ever been to a dinner party with one? Nowhere is a scientist more easily identifiable than in a social situation. They’re the one with the [...]

By | November 17th, 2017|For Scientist-Turned-Entrepreneurs, Industry Support, News|

Evolva and Northumbria University to collaborate in studies on human health benefits of Veri-te TM resveratrol

16 November, 2017 – Evolva announced today a collaboration with Northumbria University’s Brain, Performance and Nutrition Research Centre in the UK, for the study of Veri-teTM resveratrol.  The collaboration will include a series of human intervention studies that will assess the inter-relationships between obesity, gut [...]

By | November 16th, 2017|Consumer Products & Manufacturing, Food, News, Press Releases|

Oxford Genetics Licenses SnapFast™ Expression Vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to [...]

By | November 16th, 2017|DNA Synthesis, Industry Providers, News|

Autolus Announces Publication of a Unique Therapeutic Approach for Treatment of Patients with T-Cell Lymphomas in Nature Medicine

London, 14 November 2017  - Autolus Limited, a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation engineered T-cell therapies, today announced the publication of an article in Nature Medicine describing a unique targeting strategy for the treatment [...]

By | November 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

SnapGene and Synbio Technologies Partner to Streamline Construct Design and Synthesis

SnapGene customers can now order synthetic biology constructs directly from the software through Synbio Technologies. November 13, 2017 10:00 AM Eastern Standard Time CHICAGO--(BUSINESS WIRE)--Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to [...]

By | November 14th, 2017|CAD Tools, DNA Synthesis, Industry Providers, News|